1. Home
  2. NVGS vs EVO Comparison

NVGS vs EVO Comparison

Compare NVGS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVGS
  • EVO
  • Stock Information
  • Founded
  • NVGS 1997
  • EVO 1993
  • Country
  • NVGS United Kingdom
  • EVO Germany
  • Employees
  • NVGS N/A
  • EVO N/A
  • Industry
  • NVGS Marine Transportation
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVGS Consumer Discretionary
  • EVO Health Care
  • Exchange
  • NVGS Nasdaq
  • EVO Nasdaq
  • Market Cap
  • NVGS 1.1B
  • EVO 1.2B
  • IPO Year
  • NVGS N/A
  • EVO 2021
  • Fundamental
  • Price
  • NVGS $14.82
  • EVO $4.00
  • Analyst Decision
  • NVGS Strong Buy
  • EVO Strong Buy
  • Analyst Count
  • NVGS 3
  • EVO 1
  • Target Price
  • NVGS $22.33
  • EVO $7.00
  • AVG Volume (30 Days)
  • NVGS 251.6K
  • EVO 44.7K
  • Earning Date
  • NVGS 11-05-2025
  • EVO 11-05-2025
  • Dividend Yield
  • NVGS 1.34%
  • EVO N/A
  • EPS Growth
  • NVGS 12.51
  • EVO N/A
  • EPS
  • NVGS 1.26
  • EVO N/A
  • Revenue
  • NVGS $566,889,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • NVGS $3.67
  • EVO N/A
  • Revenue Next Year
  • NVGS $0.11
  • EVO $10.78
  • P/E Ratio
  • NVGS $11.93
  • EVO N/A
  • Revenue Growth
  • NVGS 1.19
  • EVO N/A
  • 52 Week Low
  • NVGS $10.55
  • EVO $2.84
  • 52 Week High
  • NVGS $17.53
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • NVGS 33.46
  • EVO 62.90
  • Support Level
  • NVGS $14.87
  • EVO $3.93
  • Resistance Level
  • NVGS $15.77
  • EVO $4.06
  • Average True Range (ATR)
  • NVGS 0.33
  • EVO 0.08
  • MACD
  • NVGS -0.16
  • EVO 0.05
  • Stochastic Oscillator
  • NVGS 5.59
  • EVO 83.31

About NVGS Navigator Holdings Ltd. (Marshall Islands)

Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: